METHOD FOR PREVENTING HYPERTENSIVE DYSCIRCULATORY ENCEPHALOPATHY

摘要

The method for preventing the hypertensive dyscirculatory encephalopathy comprises the delineation of risk factors, the clinical diagnostic examinations for confirmation of hypertension and the treatment of the disease. In addition, the gene polymorphism of angiotensin receptor type II is assessed. The Candesartan, angiotensin receptor type II blocker is used in the initial dose that is adequate to then genotype determined. The arterial blood pressure and the clinical state of the patients are monitored.